Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
7.87
-0.33 (-4.02%)
At close: Jul 31, 2026, 4:00 PM EDT
7.89
+0.02 (0.25%)
After-hours: Jul 31, 2026, 5:45 PM EDT

Grifols Revenue

Grifols had revenue of 5.55B EUR in the twelve months ending June 30, 2026, down -25.50% year-over-year. In the year 2025, Grifols had annual revenue of 7.52B with 4.33% growth.

Revenue (ttm)
5.55B EUR
Revenue Growth
-25.50%
P/S Ratio
0.81
Revenue / Employee
219,712 EUR
Employees
25,247
Market Cap
6.84B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.52B312.00M4.33%
Dec 31, 20247.21B620.00M9.41%
Dec 31, 20236.59B528.03M8.71%
Dec 31, 20226.06B1.13B22.92%
Dec 31, 20214.93B-406.92M-7.62%
Dec 31, 20205.34B241.35M4.73%
Dec 31, 20195.10B611.97M13.64%
Dec 31, 20184.49B168.65M3.91%
Dec 31, 20174.32B268.24M6.62%
Dec 31, 20164.05B115.27M2.93%
Dec 31, 20153.93B579.18M17.26%
Dec 31, 20143.36B613.65M22.38%
Dec 31, 20132.74B120.79M4.61%
Dec 31, 20122.62B825.33M45.96%
Dec 31, 20111.80B804.88M81.24%
Dec 31, 2010990.73M77.54M8.49%
Dec 31, 2009913.19M98.88M12.14%
Dec 31, 2008814.31M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Pfizer63.32B
AstraZeneca61.37B
Sanofi54.60B
Novo Nordisk50.57B
Bristol-Myers Squibb Company49.19B
GSK plc44.05B
Amgen37.22B
Gilead Sciences29.74B
Revenue Rankings